MECHANISM OF EXCESS GLUCOSE PRODUCTION IN TYPE 2 DIABETES
2 型糖尿病中葡萄糖产生过多的机制
基本信息
- 批准号:8171657
- 负责人:
- 金额:$ 1.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsClinicalComputer Retrieval of Information on Scientific Projects DatabaseDataDevelopmentDiabetes MellitusDiagnosisDietDiseaseEpidemicFastingFatty acid glycerol estersFundingGluconeogenesisGlucoseGlycogenolysis InhibitionGoalsGrantHepaticHomeostasisHumanHydrolysisHyperglycemiaIn VitroIndividualInstitutionInsulin ResistanceLipidsLiverLiver FailureLiver GlycogenMetabolicMethodologyNon-Insulin-Dependent Diabetes MellitusObesityObservational StudyPatientsPhysiologyRegulationReportingResearchResearch PersonnelResourcesRodent ModelRoleSourceUnited States National Institutes of HealthWorkcarbohydrate metabolismfeedingglucose productionglycogen metabolismglycogenolysisin vivolipid metabolismpreventstable isotope
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The goal of the work is to undertake observational studies using in vitro and in vivo NMR and stable isotope methodologies to assess glycogen metabolism and its regulation in normal physiology and in obesity-associated diabetes in high-fat-fed and fasted conditions. Type 2 diabetes mellitus (T2DM) is getting epidemic threatening millions of people and its increase is tightly related with the rapid increase of obesity throughout the world. Insulin resistance may proceed decades before the onset of diabetes and it is common in obese individuals. My long term goal in research is finding primary cause(s) of insulin resistance and elucidating the interactions between glucose and lipid metabolism in T2DM, which are essential for strategy development to prevent the onset of diabetes and to fine a cure or better treatments for the disease. A key clinical observation for diagnosis of diabetes is fasting hyperglycemia. Hepatic glucose overproduction contributes fasting hyperglycemia, but controversial data have been reported about the roles of glycogenolysis and gluconeogenesis in T2DM. Recently I found that preserved liver glycogen in fasting resulted in excess glycogenolysis, and subsequently contributed fasting hyperglycemia in rodent models for obesityassociated T2DM. This observation could be important in understanding the failure of hepatic glucose autoregulation in obese T2DM patients because increased fasting hepatic glycogen was reported in obese humans and T2DM patients. Excess liver glycogen in fasting could be critical in fasting hyperglycemia in those individuals because endogenous glucose production is sensitive to the amount of hepatic glycogen available for hydrolysis. In this proposal, liver metabolic changes in obesity and in obesity-associated T2DM will be evaluated in the connection with systemic metabolic fluxes of whole animals. A short-term high-fat diet induced hepatic insulin resistance and the interaction between lipid and carbohydrate metabolism in obesity-associated T2DM will be evaluated focusing hepatic glycogen. It will be determined whether inhibition of glycogenolysis alters fasting hyperglycemia in rodent models of obesity-associated T2DM.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
这项工作的目标是利用体外和体内核磁共振和稳定同位素方法进行观察性研究,以评估高脂肪喂养和禁食条件下正常生理和肥胖相关糖尿病中的糖原代谢及其调节。 2型糖尿病(T2DM)正在流行,威胁着数百万人,其增长与全球肥胖率的迅速增加密切相关。胰岛素抵抗可能在糖尿病发病前几十年就已经出现,并且在肥胖个体中很常见。我的长期研究目标是找到胰岛素抵抗的主要原因,并阐明 T2DM 中葡萄糖和脂质代谢之间的相互作用,这对于制定预防糖尿病发作以及更好地治愈该疾病的策略至关重要。诊断糖尿病的一个关键临床观察是空腹高血糖。肝葡萄糖过量产生导致空腹高血糖,但关于糖原分解和糖异生在 T2DM 中的作用的数据存在争议。最近,我发现空腹时保留的肝糖原会导致糖原分解过量,并随后在肥胖相关 T2DM 啮齿动物模型中导致空腹高血糖。这一观察结果对于理解肥胖 T2DM 患者肝脏葡萄糖自动调节的失败可能很重要,因为据报道肥胖人和 T2DM 患者空腹肝糖原增加。空腹时过量的肝糖原可能对这些个体的空腹高血糖至关重要,因为内源性葡萄糖的产生对可用于水解的肝糖原的量敏感。在该提案中,将结合整个动物的全身代谢通量来评估肥胖和肥胖相关 T2DM 中的肝脏代谢变化。将评估短期高脂肪饮食诱导的肝脏胰岛素抵抗以及肥胖相关 T2DM 中脂质和碳水化合物代谢之间的相互作用,重点关注肝糖原。 将确定抑制糖原分解是否会改变肥胖相关 T2DM 啮齿动物模型中的空腹高血糖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EUNSOOK JIN其他文献
EUNSOOK JIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EUNSOOK JIN', 18)}}的其他基金
13C asymmetry in blood glucose as a marker for oxidative stress in liver
血糖中的 13C 不对称性作为肝脏氧化应激的标志
- 批准号:
8891416 - 财政年份:2014
- 资助金额:
$ 1.05万 - 项目类别:
13C asymmetry in blood glucose as a marker for oxidative stress in liver
血糖中的 13C 不对称性作为肝脏氧化应激的标志
- 批准号:
9288174 - 财政年份:2014
- 资助金额:
$ 1.05万 - 项目类别:
MECHANISM OF EXCESS GLUCOSE PRODUCTION IN TYPE 2 DIABETES
2 型糖尿病中葡萄糖产生过多的机制
- 批准号:
8363906 - 财政年份:2011
- 资助金额:
$ 1.05万 - 项目类别:
MECHANISM OF EXCESS GLUCOSE PRODUCTION IN TYPE 2 DIABETES
2 型糖尿病中葡萄糖产生过多的机制
- 批准号:
7956975 - 财政年份:2009
- 资助金额:
$ 1.05万 - 项目类别:
Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM
过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用
- 批准号:
7766217 - 财政年份:2008
- 资助金额:
$ 1.05万 - 项目类别:
EXCESS GLUCOSE PRODUCTION: GLYCOGEN OR TCA-CYCLE GLUCONEOGENESIS?
葡萄糖产生过多:糖原或 TCA 循环糖异生?
- 批准号:
7724125 - 财政年份:2008
- 资助金额:
$ 1.05万 - 项目类别:
Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM
过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用
- 批准号:
7470349 - 财政年份:2008
- 资助金额:
$ 1.05万 - 项目类别:
Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM
过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用
- 批准号:
7590345 - 财政年份:2008
- 资助金额:
$ 1.05万 - 项目类别:
Role of excess glycogenolysis in fasting hyperglycemia in obesity-associated T2DM
过量糖原分解在肥胖相关 T2DM 空腹高血糖中的作用
- 批准号:
7804877 - 财政年份:2008
- 资助金额:
$ 1.05万 - 项目类别:
EXCESS GLUCOSE PRODUCTION: GLYCOGEN OR TCA-CYCLE GLUCONEOGENESIS?
葡萄糖产生过多:糖原或 TCA 循环糖异生?
- 批准号:
7600859 - 财政年份:2007
- 资助金额:
$ 1.05万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
- 批准号:
2734768 - 财政年份:2026
- 资助金额:
$ 1.05万 - 项目类别:
Studentship
EAGER: Integrating Pathological Image and Biomedical Text Data for Clinical Outcome Prediction
EAGER:整合病理图像和生物医学文本数据进行临床结果预测
- 批准号:
2412195 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Standard Grant
Exploring the Impact of Clinical Diagnosis on Health and Education Outcomes for Children Receiving Special Educational Needs support for Autism
探索临床诊断对接受自闭症特殊教育需求支持的儿童的健康和教育结果的影响
- 批准号:
ES/Z502431/1 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Fellowship
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
- 批准号:
MR/Y009657/1 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Fellowship
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Fellowship
Strategy for improving clinical obesity therapeutics
改善临床肥胖治疗的策略
- 批准号:
MR/Y014707/1 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Research Grant
VITAL: VIrtual Twins as tools for personalised clinicAL care
VITAL:虚拟双胞胎作为个性化临床护理的工具
- 批准号:
10106393 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
EU-Funded
Quantum-Enabled Brain Imaging: A Pathway to Clinical Utility
量子脑成像:临床应用的途径
- 批准号:
10107115 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Small Business Research Initiative
Determining the clinical utility of BioEP: a multisite, prospective, study
确定 BioEP 的临床效用:一项多中心前瞻性研究
- 批准号:
10090508 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Investment Accelerator
Presymptom: development of a novel machine-learning-derived diagnostic test to rule out infection to enable enhanced clinical care and better targeted anti-microbial use
症状前:开发一种新型的机器学习诊断测试来排除感染,从而加强临床护理和更有针对性的抗菌药物使用
- 批准号:
10089281 - 财政年份:2024
- 资助金额:
$ 1.05万 - 项目类别:
Investment Accelerator